TG Therapeutics, Inc. (TGTX) Earnings
|
Expand Research on TGTX
| Next EPS Date | 8/4/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +212.7% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -13.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/26  |
Q126 | N/A | $0.28 | N/A | N/A | $197.47M | = | N/A | N/A | ||
| 2/26/26 | Q425 | $0.14 | $0.37 | -$0.23 | $192.57M | $188.73M | = |  | | Details | |
| 11/3/25 | Q325 | $2.43 | $0.22 | +$2.21 | $161.7M | $152.23M | = | | | Details | |
| 10/30/25 |
Q325 | N/A | $0.22 | N/A | N/A | $152.23M | = | N/A | N/A | ||
| 8/4/25 | Q225 | $0.17 | $0.19 | -$0.02 | $141.1M | $137.4M | = | | | Details | |
| 5/5/25 | Q125 | $0.03 | $0.16 | -$0.13 | $119.7M | $117.13M | = | | | Details | |
| 3/3/25 | Q424 | $0.15 | $0.08 | +$0.07 | $108.19M | $97.66M | = | | | Details | |
| 11/4/24 | Q324 | $0.02 | $0.02 | $0.00 | $83.3M | $81.21M | N/A | | | Details |
